Position in ROIV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,088,460
+$2,595,043 QoQ
Shares Held
219,800
+36.5% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Dec 31, 2025CallValue
$13,219,640
CallShares
609,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caption Management, LLC holds $170,916,514 across 70 Biotechnology names. ROIV ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
378,480 | $25,615,526 | |
| 2 | IMCR |
Immunocore Holdings plc
|
661,786 | $19,952,847 | |
| 3 | CYTK |
Cytokinetics Inc
|
245,000 | $16,147,950 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
370,000 | $14,504,000 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
260,000 | $10,480,600 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
272,292 | $7,626,898 | |
| 7 | AVTX |
Avalo Therapeutics, Inc.
|
455,000 | $6,793,150 | |
| 8 | ROIV |
Roivant Sciences Ltd.
This page
|
219,800 | $6,088,460 |
All Filings in ROIV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,088,460 | 219,800 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,219,640 | 609,200 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $3,493,417 | 160,987 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,545,610 | 697,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $22,540,000 | 2,000,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $2,892,569 | 256,661 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,589,709 | 256,661 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,778,498 | 150,338 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,818,704 | 157,600 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $1,961,800 | 170,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,314,168 | 124,330 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $1,683,377 | 149,900 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $3,729,424 | 319,300 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $467,200 | 40,000 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||